LAZCLUZE 240 mg
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Lazertinib (Lazertinib Mesylate)
- Strength
- 240 mg
- Form
- tablet
- ATC code
- L01EB09
- Registered in
- Canada · Janssen Inc
- Prescription
- Prescription only
- DIN
- 02555972
Source: Drug Product Database · 2026-09-30
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
Spain 1 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| LAZCLUZE | 240 mg · comprimido recubierto con película | Prescription only | Janssen-Cilag International N.V | 1241886005 |
Source: CIMA — Centro de Información online de Medicamentos (Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)) · 2026-09-30 · Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA.
Netherlands 1 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Lazcluze 240 mg filmomhulde tabletten | 240 mg · filmomhulde tablet | Prescription only | Janssen-Cilag International NV | EU/1/24/1886 |
Source: Geneesmiddeleninformatiebank (College ter Beoordeling van Geneesmiddelen (CBG-MEB)) · 2026-09-30 · Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site.
Same active substance, but no match for this strength and form
- European Union: 1 products · Every strength and form
- Switzerland: 2 products · Every strength and form